Connect with us

Health

The Women Most Affected by Abortion Bans

Published

on

The Women Most Affected by Abortion Bans

Abortion bans successfully prevented some women from getting abortions in the immediate aftermath of the Supreme Court’s overturning of Roe v. Wade, according to a detailed new study of birth data from 2023. The effects were most pronounced among women in certain groups — Black and Hispanic women, women without a college degree, and women living farthest from a clinic.

Abortion has continued to rise since the period the data covers, especially through pills shipped into states with bans. But the study identifies the groups of women who are most likely to be affected by bans.

For the average woman in states that banned abortion, the distance to a clinic increased to 300 miles from 50 miles, resulting in a 2.8 percent increase in births relative to what would have been expected without a ban.

For Hispanic women living 300 miles from a clinic, births increased 3.8 percent. For Black women, it was 3.2 percent, and for white women 2 percent.

“It really tracks, both that women who are poorer and younger and have less education are more likely to have an unintended pregnancy, and more likely to be unable to overcome the barriers to abortion care,” said Dr. Alison Norris, an epidemiology professor at Ohio State who helps lead a nationwide abortion counting effort and was not involved in the new study.

Advertisement

The working paper, released Monday by the National Bureau of Economic Research, is the first to analyze detailed local patterns in births soon after the Dobbs decision in 2022, a period when abortion was declining or about flat nationwide.

Unexpectedly, abortions have increased nationwide since then. Researchers say this is evidence of unmet demand for abortions before Dobbs. Since then, telehealth and a surge in financial assistance have made it easier for women to get abortions, in both states with bans and where it remained legal.

But the new findings suggest that the assistance didn’t reach everyone. State bans appear to have prevented some women from having abortions they would have sought if they were legal.

The national increase in abortion masks that some people were “trapped by bans,” said Caitlin Myers, a professor of economics at Middlebury College and an author of the paper with Daniel Dench and Mayra Pineda-Torres at Georgia Tech. “What’s happened is an increase in inequality of access: Access is increasing for some people and not for others.”

The rise in births was small, suggesting that most women who wanted abortions had still gotten them, said Diana Greene Foster, the director of research at Advancing New Standards in Reproductive Health at the University of California at San Francisco. Still, she said, the new study was persuasive in showing the effects of bans: “I now feel more convinced that some people really did have to carry pregnancies to term.”

Advertisement

John Seago, the president of Texas Right to Life, said that a federal abortion ban would work better than a patchwork of state policies, and that states like Texas needed to do more to reduce out-of-state travel and mail-order abortion pills. But he did think Texas’ law was making a difference.

“We obviously are seeing the evidence that the bans are actually preventing abortions,” he said. “They’re actually saving lives.”

Previous studies have measured changes in the abortion rate, but Professor Myers said looking at the number of babies born is the most definitive way to know whether abortion bans actually work. Research from the years before Roe was overturned showed that longer distances from clinics affected abortions and births.

“This is the paper I’ve been waiting to write for years,” she said. “These are the data I was waiting for.”

The data she wanted was detailed birth certificates filed in 2023. Mothers include information about their age, race, marital status, level of education and home address in nearly every state, making demographic comparisons possible. The researchers used a statistical method that compared places with similar birthrates before Dobbs to estimate how much a ban changed the expected birthrate.

Advertisement

They also used county-level data to look at changes in births within states. In counties in states with bans where the distance to the nearest clinic in another state didn’t change, births increased 1 percent. In counties where the distance increased by more than 200 miles, births increased 5 percent.

In Texas, the largest state with an abortion ban, births increased more in Houston, where the nearest clinic is 600 miles away in Kansas, than they did in El Paso, where the nearest clinic is 20 miles away in New Mexico. Similarly, births increased more in the South, where states are surrounded by other states with bans, but very little in eastern Missouri, where there are abortion clinics across the border in Illinois.

The researchers also looked at appointment availability at nearby clinics, because some clinics have been overrun with people traveling from other states. They found that if women were unable to get an appointment within two weeks, births increased even more.

Still, even in places with bans that had no change in distance to the nearest clinic or appointment availability there, relative births increased slightly, which Professor Myers attributed to “a chilling effect” of bans.

The findings are in line with other research. A previous analysis, using state-level data through 2023 and a different statistical method, found that births increased 1.7 percent, and more among women who were Black or Hispanic, unmarried, without college degrees, or on Medicaid.

Advertisement

“Using different methods, using slightly different data, we’re coming to the same conclusion about the disparate impacts of these policies on populations,” said Suzanne Bell, a demographer at Johns Hopkins and an author of that paper. “I think that’s adding further evidence to the notion that these are real impacts that we’re capturing.”

Since the study’s county-level data ends after 2023, it’s possible that births in states with bans have decreased since then. Abortions nationwide have continued to increase, including for women in states with bans.

Doctors in states that passed so-called shield laws, which protect them from legal liability if they send pills into states with bans, began doing so in earnest during the summer of 2023. Abortions done this way would not affect birth data until 2024.

But using provisional state-level birth data from 2024, the new paper found almost no change in births from 2023. This data is less reliable, but researchers said that even with shield laws, some women are still unlikely to get an abortion — especially those with fewer resources, who may not know about telehealth abortion sites or are wary of ordering pills online.

Advertisement

Health

Simple lifestyle changes could slash heart attack risk for millions, scientists report

Published

on

Simple lifestyle changes could slash heart attack risk for millions, scientists report

NEWYou can now listen to Fox News articles!

Those at risk of type 2 diabetes may be able to prevent heart problems later.

A new study published in The Lancet Diabetes & Endocrinology discovered that lowering the blood sugar of those with prediabetes could reduce the risk of heart attack by half.

Diabetes researchers and endocrine experts across Europe, China and the U.S. investigated how bringing blood sugar back to normal levels affected the chances of heart problems later in life, based on a 20-year American study and a 30-year Chinese study, according to a press release.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

In both studies, the prediabetic participants were coached to make appropriate lifestyle changes to lower blood sugar (the amount of glucose in the bloodstream) through diet and exercise, also targeting weight loss.

Participants worked to lower blood sugar through diet and exercise targeted at weight loss. (iStock)

The researchers split the participants into a remission group (where blood sugar returned to normal) and a non-remission group, which included those still in the prediabetes range. They then determined who in these groups had died from heart disease or were hospitalized for heart failure.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Participants who went into remission had a 58% lower risk of dying from heart disease and being hospitalized for heart failure. This group also had a lower risk of other major heart events and lower overall death rates.

Advertisement

These heart-protective benefits lasted for decades after the program ended, the researchers found.

Those in prediabetes remission had their risk of a heart event reduced by more than half. (iStock)

“Reaching prediabetes remission is linked to a decades-long benefit, halving the risk of cardiovascular death or hospitalization for heart failure in diverse populations,” the researchers commented in the publication of the study. “Targeting remission might represent a new approach to cardiovascular prevention.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

In an interview with Fox News Digital, Dr. Andreas Birkenfeld, study co-author and professor of medicine at the University Hospital Tübingen in Germany, reiterated that reaching prediabetes remission is not only relevant for reducing the progression of type 2 diabetes, but may also be associated with a “meaningful reduction in… heart attack risk, cardiac death and heart failure.” 

Advertisement

“Importantly, this underscores that prediabetes is a modifiable stage where timely, evidence-based interventions (especially lifestyle measures, and in selected cases, medication) can make a real difference,” he added.

“Reaching prediabetes remission is linked to a decades-long benefit, halving the risk of cardiovascular death or hospitalization for heart failure in diverse populations,” the researchers commented. (iStock)

The study did have some limitations, including that it is based on analysis of trials not originally designed to measure cardiovascular outcomes, which means the results show association but cannot prove causation.

In addition, unmeasured lifestyle and health factors, population differences and lack of randomization for heart outcomes may have influenced the reduced cardiovascular risk, the researchers acknowledged.

“This underscores that prediabetes is a modifiable stage where timely, evidence-based interventions … can make a real difference.”

Advertisement

Birkenfeld suggested that those with prediabetes should ask their doctors the following questions: “What is my current status? What is my personal cardiovascular risk? What is my target blood glucose level?”

Patients should also inquire about the frequency of testing for blood sugar and key risk factors like blood pressure, cholesterol and other related conditions, such as kidney function or sleep apnea, he advised.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“If lifestyle changes aren’t enough or my risk is high, would medication be appropriate for me — and what are the benefits and downsides?” the researcher asked as an example.

About 98 million American adults, more than one in three, have prediabetes, according to CDC data. Eight in 10 of these adults are unaware that they have the disease.

Advertisement

Continue Reading

Health

New Weight Loss Drug Beats Ozempic and Eases Joint Pain With ‘Insane’ Results, Doctors Say

Published

on

New Weight Loss Drug Beats Ozempic and Eases Joint Pain With ‘Insane’ Results, Doctors Say


Advertisement


‘Triple G’ Retatrutide Shows ‘Insane’ Results on Weight Loss, Knee Pain | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Major study reveals why COVID vaccine can trigger heart issues, especially in one group

Published

on

Major study reveals why COVID vaccine can trigger heart issues, especially in one group

NEWYou can now listen to Fox News articles!

One of the most widely known risks linked to the COVID-19 vaccine is myocarditis, especially in young males — and now a new Stanford study has shed some light on why this rare effect can occur.

Myocarditis, which is inflammation of the heart, occurs in about one in 140,000 people who receive the first dose of the vaccine and one in 32,000 after the second dose, according to a Stanford press release. Among males 30 and younger, that rises to one in 16,750.

Symptoms of the condition include chest pain, shortness of breath, fever and palpitations, which can occur just one to three days after vaccination. Another marker is heightened levels of cardiac troponin, which indicates that the heart muscle has been damaged.

LOWER DEMENTIA RISK LINKED TO ROUTINE VACCINATION IN MAJOR NEW ANALYSIS

Advertisement

In most cases, people who experience myocarditis recover quickly and restore full heart function, according to study author Joseph Wu, MD, PhD, the director of the Stanford Cardiovascular Institute and a professor of medicine and radiology.

One of the most widely known risks linked to the COVID-19 vaccine is myocarditis, especially in young males. (iStock)

“It’s not a heart attack in the traditional sense,” Wu told Fox News Digital. “There’s no blockage of blood vessels as found in most common heart attacks. When symptoms are mild and the inflammation hasn’t caused structural damage to the heart, we just observe these patients to make sure they recover.”

In rare cases, however, severe heart inflammation can lead to hospitalizations, critical illness or death, Wu noted.

Finding the cause

The new Stanford study — conducted in collaboration with The Ohio State University — aimed to determine the reasons for the myocarditis. The research team analyzed blood samples from vaccinated people, some with myocarditis and some without. 

Advertisement

They found that those with myocarditis had two proteins in their blood, CXCL10 and IFN-gamma, which are released by immune cells. Those proteins then activate more inflammation.

COVID VACCINE UNDER NEW SCRUTINY AFTER STUDIES REVEAL POSSIBLE HEALTH RISKS

“We think these two are the major drivers of myocarditis,” said Wu. “Your body needs these cytokines to ward off viruses. It’s essential to immune response, but can become toxic in large amounts.”

In mouse and heart tissue models, high levels of these proteins led to signs of heart irritation, similar to mild myocarditis.

Prevention mechanism

“One of the most striking findings was how much we could reduce heart damage in our models by specifically blocking these two cytokines, without shutting down the entire (desired) immune response to the vaccine,” Wu told Fox News Digital, noting that a targeted, “fine‑tuning” immune approach might be enough to protect the heart.

Advertisement

Myocarditis, which is inflammation of the heart, occurs in about one in 140,000 people who receive the first dose of the vaccine and one in 32,000 after the second dose. (iStock)

“This points to a possible future way to prevent or treat myocarditis in people who are at the highest risk, while keeping the benefits of vaccination,” he added.

The team also found that genistein, an estrogen-like natural compound found in soybeans, reduced inflammation in lab tests, but this has not yet been tested in humans.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The findings were published in the journal Science Translational Medicine.

Advertisement

“This is a very complex study,” Fox News senior medical analyst Dr. Marc Siegel told Fox News Digital. “Myocarditis is very rare, and the immune mechanism makes sense.”

CLICK HERE FOR MORE HEALTH STORIES

“Myocarditis is worse with COVID — much more common, and generally much more severe.” 

Wu agreed, adding that COVID infection is about 10 times more likely to cause myocarditis compared to mRNA-based vaccines.

‘Crucial tool’

The researchers emphasized that COVID-19 vaccines have been “heavily scrutinized” for safety and have been shown to have an “excellent safety record.”

Advertisement

In rare cases, however, severe heart inflammation can lead to hospitalizations, critical illness or death. (iStock)

“mRNA vaccines remain a crucial tool against COVID‑19, and this research helps explain a rare side effect and suggests ways to make future vaccines even safer, rather than a reason to avoid vaccination,” Wu said.

“The overall benefits of COVID‑19 vaccination still clearly outweigh the small risk of myocarditis for nearly all groups.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The study did have some limitations, primarily the fact that most of the data came from experimental systems (mice and human cells in the lab), which cannot fully capture how myocarditis develops and resolves in real patients, according to Wu.

Advertisement

“This points to a possible future way to prevent or treat myocarditis in people who are at the highest risk.”

“These findings do not change what people should do right now, because our work is still at the preclinical (mouse and human cells) stage,” he said. “Clinical studies will be needed to confirm whether targeted treatments are safe and effective.”

The researcher also added that myocarditis risk could rise with other types of vaccines.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“Other vaccines can cause myocarditis and inflammatory problems, but the symptoms tend to be more diffuse,” he said in the release. “Plus, mRNA-based COVID-19 vaccines’ risks have received intense public scrutiny and media coverage. If you get chest pains from a COVID vaccine, you go to the hospital to get checked out, and if the serum troponin is positive, then you get diagnosed with myocarditis. If you get achy muscles or joints from a flu vaccine, you just blow it off.”

Advertisement

The study was funded by the National Institutes of Health and the Gootter-Jensen Foundation.

Continue Reading
Advertisement

Trending